RETRACTED: PRDM16 Upregulation Induced by MicroRNA-448 Inhibition Alleviates Atherosclerosis via the TGF-β Signaling Pathway Inactivation
A Retraction of the Original Research Article
PRDM16 upregulation induced by MicroRNA-448 inhibition alleviates atherosclerosis via the TGF-β signaling pathway inactivation
by Liu D, Song J, Ji X, Liu Z, Li T and Hu B (2020). Front. Physiol. 11:846. doi: 10.3389/fphys.2020.00846
The journal retracts the 11 August 2020 article cited above.
Following publication, concerns were raised regarding the validity of the data in the article. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.
This retraction was approved by the Chief Editors of Frontiers of Physiology and the Chief Executive Editor of Frontiers. The authors have not responded to correspondence regarding this retraction.
Citation: Frontiers Editorial Office (2023) Retraction: PRDM16 upregulation induced by MicroRNA-448 inhibition alleviates atherosclerosis via the TGF-β signaling pathway inactivation. Front. Physiol. 14:1327004. doi: 10.3389/fphys.2023.1327004
Received: 24 October 2023; Accepted: 24 October 2023;
Published: 30 October 2023.
Approved by:
Gerald A. Meininger, University of Missouri, United StatesCopyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org